This is in alignment with previous research demonstrating that MKP-1, a crucial negative regulator of MAPKs, can reduce Aβ generation and alleviate cognitive impairments in AD models [61], thereby validating our observation. The gene discussed is DUSP1; the disease is Cognitive impairment.